FIELD: medicine, dermatology.
SUBSTANCE: the suggested therapeutic method includes complex therapy with "Affinoleukin" being its one component. Depending upon the severity of disease flow, necessary dosages and the mode for preparation injection have been elaborated. The method provides efficient treatment due to competitive interaction of "Affinoleukin" with homologous antigens participating in pathogenesis of disease development that leads to interruption of disease symptoms being resistant to other kinds of therapy.
EFFECT: more prolonged period of remission.
4 cl, 3 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF ATOPIC DERMATITIS | 2003 |
|
RU2235556C1 |
METHOD OF TREATMENT OF ATOPIC DERMATITIS IN CHILDREN | 2006 |
|
RU2348423C2 |
METHOD OF TREATING ATOPIC DERMATITIS IN CHILDREN WITH DIAGNOSED CYTOMEGALOVIRUS INFECTION | 2007 |
|
RU2402776C2 |
METHOD OF TREATING ATOPIC DERMATITIS | 2011 |
|
RU2468835C1 |
WAY OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2361604C1 |
METHOD OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2340348C1 |
APPLICATION OF SEMAX PREPARATION FOR TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2347582C1 |
METHOD OF ATOPIC DERMATITIS TREATMENT | 2006 |
|
RU2329837C2 |
METHOD OF PREDICTING DEGREE OF ATOPIC DERMATITIS IN CHILDREN | 2016 |
|
RU2630063C1 |
METHOD FOR TREATING ATOPIC DERMATITIS | 2001 |
|
RU2199304C1 |
Authors
Dates
2005-03-27—Published
2002-09-02—Filed